Literature DB >> 15340150

Type II platelet-activating factor-acetylhydrolase is essential for epithelial morphogenesis in Caenorhabditis elegans.

Takao Inoue1, Asako Sugimoto, Yuka Suzuki, Masayuki Yamamoto, Masafumi Tsujimoto, Keizo Inoue, Junken Aoki, Hiroyuki Arai.   

Abstract

Type II platelet-activating factor-acetylhydrolase [PAF-AH (II)] is an N-myristoylated enzyme that contains a lipase/esterase catalytic motif and selectively hydrolyzes the sn-2 acetyl ester of PAF and other short-chain acyl groups attached to phosphoglycerides. However, the physiological role of this enzyme remains to be elucidated. PAF-AH (II) is conserved in a variety of species ranging from a simple multicellular organism, Caenorhabditis elegans, to mammals. C. elegans possesses two homologous PAF-AH (II) genes, named paf-1 and paf-2. In this study, we generated these two loss-of-function mutants to elucidate the in vivo PAF-AH (II) function. Surprisingly, mutants of paf-2, a major isoform of C. elegans PAF-AH (II)s, exhibits gross defects in epithelial sheet formation, resulting in unsuccessful subsequent morphogenesis with complete penetrance. Moreover, paf-2 RNA interference worms show a variable abnormal morphology, including ectopic protrusions and a lumpy shape at the late embryonic and early larval stages due to epithelial organization defects. Consistent with these phenotypes, PAF-AH (II) is predominantly expressed in epithelial cells of C. elegans. This study demonstrates that PAF-AH (II) is essential for epithelial morphogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15340150      PMCID: PMC516553          DOI: 10.1073/pnas.0405507101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

Review 1.  Mammalian platelet-activating factor acetylhydrolases.

Authors:  D M Stafforini; S M Prescott; G A Zimmerman; T M McIntyre
Journal:  Biochim Biophys Acta       Date:  1996-06-11

2.  cDNA cloning and expression of intracellular platelet-activating factor (PAF) acetylhydrolase II. Its homology with plasma PAF acetylhydrolase.

Authors:  K Hattori; H Adachi; A Matsuzawa; K Yamamoto; M Tsujimoto; J Aoki; M Hattori; H Arai; K Inoue
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

3.  An actin-mediated two-step mechanism is required for ventral enclosure of the C. elegans hypodermis.

Authors:  E M Williams-Masson; A N Malik; J Hardin
Journal:  Development       Date:  1997-08       Impact factor: 6.868

4.  A novel method of preparing rat-monoclonal antibody-producing hybridomas by using rat medial iliac lymph node cells.

Authors:  Y Kishiro; M Kagawa; I Naito; Y Sado
Journal:  Cell Struct Funct       Date:  1995-04       Impact factor: 2.212

5.  Phospholipids from the free-living nematode Caenorhabditis elegans.

Authors:  K Satouchi; K Hirano; M Sakaguchi; H Takehara; F Matsuura
Journal:  Lipids       Date:  1993-09       Impact factor: 1.880

6.  The catalytic subunit of bovine brain platelet-activating factor acetylhydrolase is a novel type of serine esterase.

Authors:  M Hattori; H Adachi; M Tsujimoto; H Arai; K Inoue
Journal:  J Biol Chem       Date:  1994-09-16       Impact factor: 5.157

7.  Cloning and expression of a cDNA encoding the beta-subunit (30-kDa subunit) of bovine brain platelet-activating factor acetylhydrolase.

Authors:  M Hattori; H Adachi; J Aoki; M Tsujimoto; H Arai; K Inoue
Journal:  J Biol Chem       Date:  1995-12-29       Impact factor: 5.157

8.  Purification and characterization of platelet-activating factor acetylhydrolase II from bovine liver cytosol.

Authors:  K Hattori; M Hattori; H Adachi; M Tsujimoto; H Arai; K Inoue
Journal:  J Biol Chem       Date:  1995-09-22       Impact factor: 5.157

9.  Trimethylpsoralen induces small deletion mutations in Caenorhabditis elegans.

Authors:  M D Yandell; L G Edgar; W B Wood
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

10.  The Caenorhabditis elegans LIN-26 protein is required to specify and/or maintain all non-neuronal ectodermal cell fates.

Authors:  M Labouesse; E Hartwieg; H R Horvitz
Journal:  Development       Date:  1996-09       Impact factor: 6.868

View more
  7 in total

Review 1.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

2.  Spatiotemporal localization of D-amino acid oxidase and D-aspartate oxidases during development in Caenorhabditis elegans.

Authors:  Yasuaki Saitoh; Masumi Katane; Tomonori Kawata; Kazuhiro Maeda; Masae Sekine; Takemitsu Furuchi; Hiroyuki Kobuna; Taro Sakamoto; Takao Inoue; Hiroyuki Arai; Yasuhito Nakagawa; Hiroshi Homma
Journal:  Mol Cell Biol       Date:  2012-03-05       Impact factor: 4.272

3.  Oligomeric state regulated trafficking of human platelet-activating factor acetylhydrolase type-II.

Authors:  Elizabeth S Monillas; Jeffrey L Caplan; Anastasia F Thévenin; Brian J Bahnson
Journal:  Biochim Biophys Acta       Date:  2015-02-20

4.  Crystallization and preliminary X-ray crystallographic analysis of human plasma platelet activating factor acetylhydrolase.

Authors:  Uttamkumar Samanta; Cheryl Wilder; Brian J Bahnson
Journal:  Protein Pept Lett       Date:  2009       Impact factor: 1.890

5.  Roles of acidic phospholipids and nucleotides in regulating membrane binding and activity of a calcium-independent phospholipase A2 isoform.

Authors:  Kylee Morrison; Kristen Witte; Jonathan R Mayers; Amber L Schuh; Anjon Audhya
Journal:  J Biol Chem       Date:  2012-09-24       Impact factor: 5.157

6.  A yeast PAF acetylhydrolase ortholog suppresses oxidative death.

Authors:  Jason M Foulks; Andrew S Weyrich; Guy A Zimmerman; Thomas M McIntyre
Journal:  Free Radic Biol Med       Date:  2008-05-03       Impact factor: 7.376

Review 7.  Lipid peroxidation generates biologically active phospholipids including oxidatively N-modified phospholipids.

Authors:  Sean S Davies; Lilu Guo
Journal:  Chem Phys Lipids       Date:  2014-04-02       Impact factor: 3.329

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.